The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility

Launched by CATALYSIS SL · Jan 31, 2022

Keywords

ClinConnect Summary

Every day, all over the world, increasingly more couples have to go to specialised centres in the hope of solving their infertility problems. In the past, female infertility was thought to be the main cause of this problem, but in the course of time, those of us who work in the field of Gynaecology, which is such a delicate issue, are convinced that the initial statistics concerning the prevalence of infertility in women is now just pure myth. The male factor is the main cause of infertility in numerous couples that go to the doctor every day, the percentage of which surpasses that of femal...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Males over 18.
• • Patient who shows alterations of the spermatogenesis and/or benign prostatic hyperplasia.
• • Patients without testicular pathology.
• • Serology and HIV negative.
• • Signed informed consent.
• Exclusion Criteria:
• • Patients with associated pathologies: epididymo-orchitis, radiation or chemotherapy.
• • Patients with a testicular pathology that has been resolved.
• • Patients with non-transmissible chronic pathologies.
• • Patients who have not agreed to take part in the study.
• • Patients that are undergoing antioxidant treatment or who have completed this treatment in the last six months.
• • Patients who are being treated with vitamins or who have completed this treatment in the last six months.
• • Patients that are being treated with anti-inflammatory medications or who have completed this treatment in the last six months.
• • Patients who are undergoing hormone treatment prescribed for andrology or who have completed this treatment in the last six months.
• • Patients with serology or who are HIV positive.